Numerous studies aimed at establishing T-PA, which activates plasminogen to plasmin, as well as PAI-1, which acts as an upstream inhibitor of T-PA, as potential pathognomonic analytes with regard to COVID-19 disease severity. The gene discussed is SERPINE1; the disease is COVID-19.